Vivo Capital, LLC Q1 2025 Filing
Filed May 12, 2025
Portfolio Value
$755.1B
Holdings
40
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (40 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SLNOSoleno Therapeutics Inc | 4,458,294 | $318.5B | 42.19% | |
| 2 | VRNAVerona Pharma PLC | 1,438,785 | $91.3B | 12.10% | |
| 3 | GONGeron Corp | 27,225,292 | $43.3B | 5.73% | |
| 4 | TRVITrevi Therapeutics Inc | 3,487,903 | $21.9B | 2.91% | |
| 5 | AVDLAvadel Pharmaceuticals PLC | 2,684,109 | $21.0B | 2.78% | |
| 6 | TERNTerns Pharmaceuticals Inc | 6,895,746 | $19.0B | 2.52% | |
| 7 | CDTXCidara Therapeutics, Inc. | 684,276 | $14.7B | 1.95% | |
| 8 | ACRSAclaris Therapeutics, Inc. | 8,888,888 | $13.6B | 1.80% | |
| 9 | VRDNViridian Therapeutics Inc | 982,576 | $13.2B | 1.75% | |
| 10 | DYNDyne Therapeutics Inc | 1,114,960 | $11.7B | 1.54% | |
| 11 | ORICOric Pharmaceuticals Inc | 2,080,450 | $11.6B | 1.54% | |
| 12 | TILInstil Bio Inc | 585,485 | $10.2B | 1.35% | |
| 13 | CMPSCompass Pathway PLC | 3,362,385 | $9.6B | 1.27% | |
| 14 | DCTHDelcath Systems, Inc. | 750,195 | $9.5B | 1.26% | |
| 15 | ZBIOZenas Biopharma Inc | 1,183,260 | $9.3B | 1.24% | |
| 16 | VSTMVerastem Inc | 1,538,461 | $9.3B | 1.23% | |
| 17 | ERASErasca Inc | 6,756,756 | $9.3B | 1.23% | |
| 18 | DRUGBright Minds Biosciences Inc | 251,572 | $9.1B | 1.20% | |
| 19 | TRMLTourmaline Bio Inc. | 591,882 | $9.0B | 1.19% | |
| 20 | ABEOAbeona Therapeutics, Inc. | 1,842,751 | $8.8B | 1.16% | |
| 21 | CATBUSDAstria Therapeutics Inc | 1,552,685 | $8.3B | 1.10% | |
| 22 | AKROAkero Therapeutics Inc | 201,168 | $8.1B | 1.08% | |
| 23 | CRVSCorvus Pharmaceuticals Holdings | 2,234,566 | $7.1B | 0.94% | |
| 24 | CMPXCompass Therapeutics Inc | 3,556,023 | $6.8B | 0.89% | |
| 25 | IOBTIO Biotech Inc | 6,173,439 | $6.7B | 0.89% | |
| 26 | COGTCogent Biosciences Inc | 1,122,471 | $6.7B | 0.89% | |
| 27 | UNCYUnicycive Therapeutics | 11,370,152 | $6.5B | 0.87% | |
| 28 | CELCCelcuity Inc | 610,500 | $6.2B | 0.82% | |
| 29 | RZLTRezolute Inc | 2,112,432 | $6.1B | 0.81% | |
| 30 | SERASera Prognostics Inc | 1,650,440 | $6.1B | 0.80% | |
| 31 | OLMAOlema Pharmaceuticals Inc | 1,505,862 | $5.7B | 0.75% | |
| 32 | RGLSRegulus Therapeutics Inc | 2,696,426 | $4.7B | 0.62% | |
| 33 | SLNSilence Therapeutics PLC | 1,105,454 | $3.1B | 0.41% | |
| 34 | SRZNSurrozen Inc | 260,000 | $3.0B | 0.40% | |
| 35 | ETNBGBP89Bio Inc | 376,804 | $2.7B | 0.36% | |
| 36 | BOLT1EURBolt Therapeutics Inc | 3,521,291 | $1.4B | 0.19% | |
| 37 | TENXTenax Therapeutics Inc | 208,333 | $1.4B | 0.18% | |
| 38 | ALLKGUSDAllakos Inc | 765,500 | $174.2M | 0.02% | |
| 39 | ALGSAligos Therapeutics Inc | 10,199 | $84.1M | 0.01% | |
| 40 | DTILPrecision Biosciences Inc | 4,675 | $22.3M | 0.00% |